Relmada Therapeutics Stock (NASDAQ: RLMD) stock price, news, charts, stock research, profile.
You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.
There are no as such competitors for Relmada Therapeutics.
Relmada Therapeutics has a consensus price target of $15.14.
The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $0.3451 last updated January 30, 2025 at 5:34 PM EST.
There are no upcoming dividends for Relmada Therapeutics.
Relmada Therapeutics’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
There is no upcoming split for Relmada Therapeutics.
Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.